Hepion Pharmaceuticals announces 1-for-50 reverse stock split

Hepion Pharmaceuticals (HEPA) announced that it will implement a 1-for-50 reverse split of the issued shares of its common stock, effective on March 17, 2025. The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on March 18, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol “HEPA.”